Bioelectric Medicine Global Market, 2020–2025
January, 2020
Growing global population, increasing difficulty in producing “blockbuster” medicines, rising costs, and increasing incidence of neurological disorders and chronic diseases globally are some of the factors that are contributing to the surge in the bioelectric medicine market. Electroceuticals are medical devices that influence changes in the body's physiology by using electrical impulses applied to the appropriate nerves. The global bioelectric medicine market include Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Retinal Implants, Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Spinal Cord Stimulators, Cochlear Implants, and others. Bioelectric Medicine market is expected to be around US$ 34 Billion by 2025.
https://www.marketresearchengine.com/bioelectric-medicine-market?mod=article_inline
Axonics Wins FDA Approval for Its Next-Generation Implantable Neurostimulator
April, 2020
Axonics (Irvine, CA) has announced the U.S. Food and Drug Administration (FDA) approval of its next-generation rechargeable implantable neurostimulator for its r-SNM system under a premarket approval (PMA) supplement. This is an implantable sacral nerve neuromodulation device for treating urinary and bowel dysfunction, including faecal incontinence and overactive bladder.
https://www.massdevice.com/axonics-wins-fda-approval-for-neurostimulator/
A Wearable Device to Help Users Reduce Stress
May 2020
BioSelf Technology Ltd (London, UK) has launched “Sensate II”, a palm-sized, pebble-like device that can be worn on the chest and synchronizes with a free mobile app. It aims to help users to improve mental wellbeing and build stress resiliency with 10-minute daily sessions. It is designed to deliver low-frequency infrasound to regulate the activity of the vagus nerve. This is the biggest of the cranial nerves and its extensive branches innervate several organs, including the heart. Appropriate stimulation can calm the body after periods of stress and anxiety. Sensate II employs the new Infrasound Resonance Engine technology to enable fast-track relaxation and serves as a shortcut to calmness. The effect of the stimulation is said to be similar to meditation or a “super-charged power nap”!
https://www.med-technews.com/news/wearable-launched-to-help-users-reduce-stress/
Brazil and South Africa to Collaborate in Fields of Bioenergy, Bioelectricity and Biofuels
February, 2020
Brazil is now the world's second-largest producer and exporter of ethanol and 65% of the country's sugarcane crop is destined for ethanol production. Bioelectricity generated from sugarcane biomass is partly consumed in the plants, contributing to assure their self-sufficiency, and partly exported to the national grid. In 2018, 61% of sugarcane biomass in bioelectricity generation were exported to the grid, which over the last 10 years represented a total injection of 150 TWh. The production of ethanol and bioelectricity has also delivered significant benefits in terms of job creation and mitigation of greenhouse gas emissions. By using liquid biofuels, Brazil has considerably lowered emissions of particulate matter, carbon monoxide, formaldehydes, reactive hydrocarbons and other volatile organic compounds precursory to photochemical smog and ozone formation, greatly contributing to urban air quality.
Cuba's First Bioelectric Plant Begins Testing Phase
January, 2020
The plant generates electricity from the biomass of the marabú bush, a naturally wild and invasive spreading plant. In addition, it will produce clean energy during the sugarcane harvest period with the use of “bagasse,” a by-product from the grinding of sugarcane. The plant contributed 300 MW to the national grid in the first 24 hours. When the plant is fully operational, it is expected to generate the equivalent of 50% of regional energy needs, saving the country some 100,000 barrels of oil a year.
https://oncubanews.com/en/cuba/cubas-first-bioelectric-plant-begins-testing-phase/